CDLX: Cardlytics, Inc Broker Consensus Forecast

Cardlytics, Inc. (CDLX) relies on exclusive access to banking transactions, creating high barriers to entry for competitors. This price chart illustrates a consensus forecast where the metric stands at 3.22. Data parsing automation has peaked, enabling the creation of personalized offers. Management is currently reorganizing the platform to optimize profits, confirming its expertise in handling Big Data.

Cardlytics Inc. - CDLX Consensus Target (period 07/04/2022 - 11/11/2026)

Analytical breakdowns for Cardlytics, Inc (CDLX)

- market price and analyst price targets:

Stock Quotes cardlytics.com|CDLX - Analyst Consensus Forecast

- market capitalization information:

Market Capitalization Cardlytics, Inc|CDLX - Total Company Value

- business book valuation details:

Net Assets per Single Share Cardlytics|CDLX - Company Net Assets|Capitalization to Book Value Ratio cardlytics.com|CDLX - Company Total Assets

- issuer credit burden and liquidity indicators:

- financial results and valuation multiples details:

CDLX - Net Income|Future Net Profit Cardlytics, Inc.|CDLX - P/E Multiple|Market Cap to Projected Earnings Cardlytics Inc.|CDLX - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Cardlytics, Inc|CDLX - Operating profit EBITDA|Net earnings per share for the last four quarters Cardlytics|CDLX - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months cardlytics.com|CDLX - Earnings growth in current year|Net earnings per one share growth forecast for next year Cardlytics, Inc.

Summary company analytics:cardlytics.com CDLX

The status of Cardlytics, Inc. (CDLX) as a trusted analytical partner for the largest banks makes the consensus forecast a key indicator of market confidence in its B2B model. This metric aggregates target valuations from leading investment houses to form a weighted average price target for determining the business's fair value; meanwhile, the gap between current quotes and this long-term consensus reflects the growth potential or overvaluation risks priced in by experts.

Competing companies